Print

V520-016

A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults

Trial Details:

I Completed
Merck April 01, 2003
MRKAd5 HIV-1 gag/pol/nef Ad5 Gag,pol,nef
MRKAd5 HIV-1 gag/pol/nef Viral Vector - Adeno
USA 259
NCT00849680
http://clinicaltrials.gov/ct2/show/NCT00849680